| Reducing risk of renal failure in obese patients - The Virtual Medical Centre |
|
|
The Virtual Medical Centre The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in the Journal of the American Society of Nephrology |